What is the status of COVID vaccines for children and adolescents? Vaccines from BioNTech-Pfizerand Moderna are currently approved in the EU for children and adolescents aged 12 to 17 years. The vaccine has shown 100% efficacy in a clinical trial with participants in that age group and was well tolerated, Moderna said. In Germany, the Standing Committee on Vaccination (STIKO) has nevertheless recommended vaccination only for those 12- to 17-year-olds “who have an increased risk of a severe course of COVID-19 disease due to previous illnesses,” citing a lack of data. German politicians, however, have been less hesitant. On August 2, the health ministers …
